- Home
- SCNI vs BJDX Comparison
SCNI vs BJDX Comparison
Compare SCNI & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- BJDX
- Stock Information
- Founded
- SCNI 2003
- BJDX 2015
- Country
- SCNI Israel
- BJDX United States
- Employees
- SCNI N/A
- BJDX N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- BJDX Medical Specialities
- Sector
- SCNI Health Care
- BJDX Health Care
- Exchange
- SCNI Nasdaq
- BJDX Nasdaq
- Market Cap
- SCNI 1.9M
- BJDX 2.2M
- IPO Year
- SCNI N/A
- BJDX 2021
- Fundamental
- Price
- SCNI $2.76
- BJDX $1.77
- Analyst Decision
- SCNI
- BJDX
- Analyst Count
- SCNI 0
- BJDX 0
- Target Price
- SCNI N/A
- BJDX N/A
- AVG Volume (30 Days)
- SCNI 22.4K
- BJDX 537.4K
- Earning Date
- SCNI 07-01-2025
- BJDX 05-19-2025
- Dividend Yield
- SCNI N/A
- BJDX N/A
- EPS Growth
- SCNI N/A
- BJDX N/A
- EPS
- SCNI 5.95
- BJDX N/A
- Revenue
- SCNI $658,000.00
- BJDX N/A
- Revenue This Year
- SCNI N/A
- BJDX N/A
- Revenue Next Year
- SCNI N/A
- BJDX $55.56
- P/E Ratio
- SCNI $0.47
- BJDX N/A
- Revenue Growth
- SCNI N/A
- BJDX N/A
- 52 Week Low
- SCNI $1.90
- BJDX $1.46
- 52 Week High
- SCNI $8.92
- BJDX $316.80
- Technical
- Relative Strength Index (RSI)
- SCNI 57.37
- BJDX 41.05
- Support Level
- SCNI $2.64
- BJDX $1.66
- Resistance Level
- SCNI $2.69
- BJDX $1.79
- Average True Range (ATR)
- SCNI 0.20
- BJDX 0.19
- MACD
- SCNI 0.09
- BJDX 0.06
- Stochastic Oscillator
- SCNI 88.24
- BJDX 36.77
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.